Location: New York, NY
CIK: 0001540951 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 12, 2021
Total Value: $287M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| VT | VANGUARD INTL EQUITY INDEX F | 1,104,408 | $102M | 35.7% | $92.58 | $86.74 | +6.7% | TT WRLD ST ETF | 922042742 |
| VSS | VANGUARD INTL EQUITY INDEX F | 487,765 | $59.43M | 20.7% | $121.84 | $113.10 | +7.7% | FTSE SMCAP ETF | 922042718 |
| IUSV | ISHARES TR | 726,403 | $45.17M | 15.8% | $62.19 | $54.66 | +13.8% | CORE S&P US VLU | 464287663 |
| HYG | ISHARES TR | 414,440 | $36.18M | 12.6% | $87.30 | $82.96 | +5.2% | IBOXX HI YD ETF | 464288513 |
| ICVT | ISHARES TR | 172,253 | $16.63M | 5.8% | $96.55 | $88.48 | +9.1% | CONV BD ETF | 46435G102 |
| EDV | VANGUARD WORLD FD | 97,773 | $14.89M | 5.2% | $152.30 | $158.95 | -4.2% | EXTENDED DUR | 921910709 |
| BKLN | INVESCO EXCH TRADED FD TR II | 467,191 | $10.41M | 3.6% | $22.28 | $21.95 | +1.5% | SR LN ETF | 46138G508 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 34,350 | $1.141M | 0.4% | $33.22 | $38.42 | -13.5% | COM | 71722W107 |
| — | AKERO THERAPEUTICS INC | 14,891 | $384K | 0.1% | $25.79 | $25.79 | — | COM | 00973Y108 |
| — | GENERATION BIO CO | 9,113 | $258K | 0.1% | $28.31 | $28.31 | — | COM | 37148K100 |